Based on data from 25 studies, ixekizumab has a lower risk of common adverse events like depression, cardiovascular events, cancer, and uveitis that are often seen with other treatments for psoriasis, psoriatic arthritis, and axial spondyloarthritis. Here to share the safety findings on ixekizumab is Dr. Atul Deodhar, Professor of Medicine and the Medical Director of Rheumatology Clinics at Oregon Health & Science University
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Learn about the risk of adverse events associated with ixekizumab in patients with psoriasis, psoriatic arthritis, and axial spondyloarthritis.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Clinician's Roundtable
The Role of Cannabis in Medicine: Canceling Chronic Pain & Combating the Opioid Crisis
- Clinician's Roundtable
Discussing Drug Diversion: An Exploration of Impact & Prevention Through Smart Data